Foetal and neonatal thyroid disorders;Patologia tiroidea nel periodo fetale e neonatale

Minerva Pediatrica

Volumn 54, Issue 5, 2002, Pages 383-400

  Radetti, G ^a   Zavallone, A ^a   Gentili, L ^a   Beck Peccoz, P ^a   Bona, G ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Autoantibodies; Grave's disease; Hypothyroidism; Thyroid diseases, foetal neonatal, pathophysiology; Thyroiditis, autoimmune

Indexed keywords

ANTITHYROID AGENT; LUGOL; POTASSIUM IODIDE; PREDNISONE; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; THYROID TRANSCRIPTION FACTOR 2; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR PROP1; UNCLASSIFIED DRUG;

ADULT; AGENESIS; BRAIN DEVELOPMENT; CLINICAL FEATURE; CONGENITAL HYPOTHYROIDISM; CRANIOFACIAL SYNOSTOSIS; DRUG INDUCED DISEASE; ECTOPIC THYROID GLAND; FEMALE; FETUS; FETUS DISEASE; FETUS MALFORMATION; GENE MUTATION; GOITER; GRAVES DISEASE; GROWTH RETARDATION; HASHIMOTO DISEASE; HEART FAILURE; HUMAN; HYDROPS; HYPERTHYROIDISM; HYPOPLASIA; HYPOTHYROIDISM; INCIDENCE; LEARNING DISORDER; MOTOR DYSFUNCTION; NEWBORN; NEWBORN DISEASE; NEWBORN SCREENING; PLACENTAL TRANSFER; PREGNANCY; PRENATAL EXPOSURE; REVIEW; SKIN APLASIA; SYMPTOM; TACHYCARDIA; THYROID DISEASE; THYROTOXICOSIS; TREATMENT OUTCOME;

AUTOIMMUNE DISEASES; FEMALE; FETAL DISEASES; GRAVES DISEASE; HUMANS; HYPOTHYROIDISM; INFANT, NEWBORN; IODINE; PREGNANCY; PREGNANCY COMPLICATIONS; THYROID DISEASES; THYROIDITIS;

EID: 0042278748     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Fisher DA, Dussault JH, Sack J, Chopra IJ. Ontogenesis of hypothalamic-pituitary-thyroid function and metabolism in man, sheep and rat. Rec Prog Horm Res 1977;33:59-116.
2. Morreale de Escobar G, Escobar del Rey I, Ruiz-Marcos A. Thyroid hormone and the developing brain. In: Dussault JH, Walker P, editors. Congenital hypothyroidism. New York: Marcel Dekker, Inc.; 1983. p.85-127.
3. Bernal J, Nunez J. Thyroid hormones and brain development. Eur J Endocrinol 1995;133:390-8.
4. Morreale de Escobar G, Pastor R, Obregon MJ, Escobar del Rey F. Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of foetal thyroid function. Endocrinology 1985;117:1890-900.
5. Vulsma T, Gons MH, de Vijlder JJM. Maternal-foetal transfer of thyroxine in congenital hypothyroidism due to a total organification defect of thyroid agenesis. N Engl J Med 1989;321:13-6.
6. Brook CGD. The consequences of congenital hypothyroidism. Clin Endocrinol 1995;42:431-2.
7. Vermiglio F, Lo Presti VP, Scaffidi Argentina G, Finocchiaro MD, Gullo D, Squatrito S et al. Maternal hypothyroxinaemia during the first half of gestation in an iodine deficient area with endemic cretinism and related disorders. Clin Endocrinol 1995;42:409-15.
8. Pop VJ, de Vries E, van Baar AL, Waelkens JJ, de Rooy HA, Horsteen M et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab 1995;80:3561-6.
9. Burrow GN, Dussault JH. Neonatal thyroid screening. New York: Raven Press; 1980.
10. Naruse H, Irie M. Neonatal screening. Amsterdam: Excerpta Medica; 1983.
11. Foley TP Jr. Congenital hypopituitarism. In: Dussault JH, Walker P, editors. Congenital hypothyroidism. New York: Dekker; 1983. p.331-48.
12. De Zegher F, Persanetti F, Vanhole C, Devlieger H, Van den Berghe G, Martial JA. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 1995;80:3127-30.
13. Delange F, Fisher DA. The thyroid gland in Clinical Paediatric Endocrinology. Oxford: Blackwell Science; 1995. p.406.
14. Krude H, Biedermann H, Schnabel D, Ambrugger P, Gruters A. Molecular pathogenesis of neonatal hypothyroidism. Horm Res 2000;53 Suppl 1:12-8.
15. Matsuura N, Yamada Y, Nohara Y. Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med 1980;303:738-41.
16. Matsuura N, Konishi J. Transient hypothyroidism group in Japan. Transient hypothyroidism in infants born to mothers with chronic thyroiditis: a nationwide study of twenty-three cases. Endocrinol Jpn 1990;37:369-79.
17. Brown RS, Bellisario RL, Botero D, Fournier L, Abrams CA, Cowger ML et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. J Clin Endocrinol Metab 1996;81:1147-51.
18. McCarrison R. Observation on endemic cretinism in the Chitral and Gilgit valleys. Lancet 1902;2:1275-80.
19. DeLong GR, Stanbury JB, Fierro-Benitez R. Neurological signs in congenital iodine-deficiency disorder (endemic cretinism). Dev Med Child Neurol 1985;27:317-24.
20. Rapa A, Marinello D, Chiorboli E, Bona G. Iodine deficiency in Italy. Lancet 1999;354:596-7.
21. Pharoah PO, Connoly KJ. Effects of maternal iodine supplementation during pregnancy. Arch Dis Child 1991;66:145-7.
22. Chiovato L, Aghini-Lombardi F, Vitti P. The impact of iodine deficiency on neurological and cognitive development: The European experience. In: Stanbury JB, editor. The damaged brain in iodine deficiency. Elsford New York: The Franklin Institute Publications, Cognizant Communication Co; 1994. p.293-8.
23. Ares S, Quero J, Duran S, Presan MJ, Herruzo R, Morreale de Escobar G. Iodine content of infant formulas and iodine intake of premature babies. Arch Dis Child 1994;71:F184-91.
24. Sava L, Delange F, Belfiore A, Purrello F, Vigneri R. Transient impairment of thyroid function in newborns from an area of endemic goiter. J Clin Endocrinol Metab 1984;59:90-5.
25. Biebermann H, Schoneberg T, Krude H, Schultz G, Gudermann T, Gruters A. Mutations in the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metab 1997;82:3471-80.
26. Nogueira CR, Nguyen LQ, Coehlo-Neto JR, Arseven OK, Jameson JL, Kopp P et al. Structural analysis of the thyrotropin receptor in four patients with congenital hypothyroidism due to thyroid hypoplasia. Thyroid 1999:9:523-9.
27. Xie J, Pannain S, Pohlenz J, Weiss RE, Moltz K, Morlton M et al. Resistance to thyrotropin (TSH) in three families is not associated with mutations in the TSH receptor or TSH. J Clin Endocrinol Metab 1997;82:3933-40.
28. Hamm HE, Gilchrist A. Heterotrimeric G proteins. Curr Opin Cell Biol 1996;8:189-96.
29. Dessauer CW, Posner BA, Gilman AG. Visualizing signal transduction: receptors, G-proteins, and adenylate cyclase. Clin Sci 1996;91:527-37.
30. Spiegel A. G proteins defects in signal transduction. Horm Res 2000;53:17-22.
31. Fischer DA. Neonatal thyroid disease in offspring of women with autoimmune thyroid disease. Thyroid Today 1986;9:1-7.
32. Fort P, Lifshitz F, Pugliese M, Klein I. Neonatal thyroid disease: differential expression in three successive offspring. J Clin Endocrinol Metab 1988;66:645-7.
33. Ramsay I. Foetal and neonatal hyperthyroidism. Contemp Rev Obstet Gynaecol 1991;3:74-8.
34. Schwab KO, Gerlich M, Broecker M, Sohlemann P, Derwahl M, Lohse MJ. Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr 1997;131:899-904.
35. Yoshimoto M, Nakayama M, Baba T, Uehara Y, Niikawa N, Ito M et al. A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Paediatr Scand 1991;80:984-7.
36. Bruinse HW, Vermeulen-Meiners C, Wit JM. Foetal treatment for thyrotoxicosis in non-thyrotoxic pregnant women. Foetal Ther 1988;3:152-7.
37. Nevard CHF, Gaunt M, Ockleford CD. The transfer of passive and active immunity. In: Chaovat G, editor. The Immunology of the Fetus. Boca Raton: CRC Press, Inc.; 1990. p.193-214.
38. Zakarija M, McKenzie JM. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 1983;57:1036-40.
39. Mortimer RH, Tyack SA, Galligan JP, Pery-Kene DA, Tan YM. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal function. Clin Endocrinol 1990;32:141-52.
40. Polak M, Leger J, Luton D, Oury JF, Vuillar DE, Boissino T et al. Foetal cord blood sampling in the diagnosis and the treatment of foetal hyperthyroidism in the offsprings of an euthyroid mother, producing thyroid stimulating immunoglobulins. Ann Endocrinol (Paris) 1997;58:338-42.
41. Glinoer D. The systematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. TEM 1998;9:403-11.
42. Mestman JH. Hyperthyroidism in pregnancy. Clin Obstet Gynecol 1997;40:45-64.
43. Glinoer D. Thyroid hyperfunction during pregnancy. Thyroid 1998;8:859-64.
44. Drury MI. Hyperthyroidism and pregnancy. J R Soc Med 1986;79:317-8.
45. Davis LE, Lucas MJ, Hankins GDV, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989;160:63-70.
46. Hollingsworth DR, Mabry CC. Congenital Graves disease. Four familial cases with long-term follow-up and perspective. Am J Dis Child 1976;130:148-55.
47. Delange F, Fisher DA. The thyroid gland in Clinical Paediatric Endocrinology. Oxford: Blackwell Science; 1995. p.422.
48. Daneman D, Howard NJ. Neonatal thyrotoxicosis: Intellectual impairment and craniostenosis in later years. J Pediatr 1980;97:257-62.
49. Page DV, Brady K, Mitchell J, Pehrson J, Wade G. The pathology of intrauterine thyrotoxicosis. Obstet Gynecol 1988;72:479-81.
50. Lamberg BA, Ikonen E, Teramo K, Wagar G, Osterlund K, Makinen T et al. Treatment of maternal hyperthyroidism with antithyroid agents and changes in thyrotropin and thyroxine in the newborn. Acta Endocrinol (Copenh) 1981;97:186-95.
51. Hollingsworth DR, Alexander NM. Amniotic fluid concentrations of iodothyronines and thyrotropin do not reliably predict foetal thyroid status in pregnancies complicated by maternal thyroid disorders or anencephaly. J Clin Endocrinol Metab 1983;57:349-55.
52. Spiegel AM. The molecular basis of disorders caused by defects in G protein. Horm Res 1997;47:89-96.
53. Hoffman WH, Sahasrananan P, Ferandos SS, Burek CL, Rose NR. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis. J Clin Endocrinol Metab 1982;54:354-6.
54. Daffos F. Foetal blood sampling. Annu Rev Med 1989;40:319-29.
55. Duprez L, Parma J, Van Sande J, Allgeir A, Leclere J, Schvartz C et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 1994;7:396-401.
56. Kopp P, van Sande J, Parma J, Duprez L, Gerber H, Joss E et al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995;19:150-4.
57. Kohn LD, Suzuki K, Hoffman WH, Tombaccini D, Marcocci C, Shimojo N et al. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. J Clin Endocrinol Metab 1997;82:3998-4009.